ESR1 and prostate cancer: When the single SNP analysis was restricted to estrogen receptor-negative (ER-) breast or advanced prostate cancer, where there were many more controls than cases included in each model, then the behavior of the score test for the single SNP associations was problematic for rare SNPs.